Cargando…
Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma
The prognostic value of albumin changes between diagnosis and end-of-treatment (EoT) in diffuse large B-cell lymphoma (DLBCL) remains unknown. We retrospectively analyzed 574 de novo DLBCL patients treated with R-CHOP from our and two other centers. All patients were divided into a training cohort (...
Autores principales: | Wei, Xiaolei, Zheng, Jingxia, Zhang, Zewen, Liu, Qiongzhi, Zhan, Minglang, Huang, Weimin, Chen, Junjie, Wei, Qi, Wei, Yongqiang, Feng, Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873605/ https://www.ncbi.nlm.nih.gov/pubmed/33585232 http://dx.doi.org/10.3389/fonc.2020.610681 |
Ejemplares similares
-
The Expression of CD30 Based on Immunohistochemistry Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2015) -
Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2017) -
Hypoalbuminemia predicts inferior outcome in patients with AIDS-related lymphoma
por: Zhang, Jinxin, et al.
Publicado: (2022) -
The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Wei, Xiaolei, et al.
Publicado: (2017) -
Publisher Correction: The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Wei, Xiaolei, et al.
Publicado: (2019)